Jazz Pharmaceuticals Severance Benefit — Form 5500 plan (Jazz Pharmaceuticals)
Plain-English plan summary
According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, Jazz Pharmaceuticals Severance Benefit is a benefit plan reported by Jazz Pharmaceuticals under EIN 05-0563787 and plan number 510. The latest loaded filing year is 2023. The filing reports 1,354 participants and not reported in the loaded dataset in end-of-year plan assets, where available in the loaded dataset.
Form 5500 plan profile · 2023
Key reported metrics
Net assets (EOY)Not reported
Participants1.4KCovered participants reported1,354
Assets / participantNot reported
Provider compensationNone reported
- Plan sponsor
- Jazz Pharmaceuticals
- EIN
- 05-0563787
- Plan number
- 510
- Plan type
- 2
- Location
- Palo Alto, CA
- Latest filing year
- 2023
Form 5500 filing history
| Filing year | Participants | Schedules | Filing |
|---|---|---|---|
| 2023 | 1,354 | — | 20250801190640NAL0010442592001 |
Reported financial statement
This plan is loaded, but Schedule H / I financial-statement detail is not present for it in the current loaded dataset.
Service provider compensation (Schedule C)
No Schedule C service provider compensation is loaded for this plan yet.